Methimazole-Induced Aplastic Anemia Caused by Hypocellular Bone Marrow with Plasmacytosis

Thyroid

Volumn 14, Issue 3, 2004, Pages 231-235

  Yamamoto, Akemi ^a   Katayama, Yasuyuki ^a   Tomiyama, Koji ^a   Hosoai, Hiroshi ^a   Hirata, Fumihiko ^a   Kimura, Fumihiko ^b   Fujita, Kazuyuki ^c   Yasuda, Hiroko ^a  

^a Self Defense Forces Central Hospital   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c Self Defense Force Hospital Yokosuka   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SALICYLIC ACID; THIAMAZOLE;

ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW DEPRESSION; CASE REPORT; CLINICAL FEATURE; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; GRANULOCYTOPENIA; GRAVES DISEASE; HUMAN; HUMAN CELL; HYPOCELLULAR BONE MARROW; IMMUNOGENICITY; JAPAN; LEUKOCYTE COUNT; LYMPHOCYTE; PLASMACYTOSIS; PRIORITY JOURNAL; SORE THROAT; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

ANEMIA, APLASTIC; ANTITHYROID AGENTS; BONE MARROW; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTE TRANSFUSION; FEMALE; GRAVES DISEASE; HUMANS; METHIMAZOLE; MIDDLE AGED; PLASMA CELLS; PLATELET TRANSFUSION;

EID: 1842534195     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072504773297911     Document Type: Article

References (14)

1. Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, Molitch ME 1983 Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 98:26-29.
2. Benker G, Reinwein D, Kahaly G, Tegler L, Alexander WD, Faßbinder J 1998 Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. Clin Endocrinol 49:451-457
3. Breier DV, P. Gonzalez RJ, Shilton G, Stivel M, Goldztein S 2001 Massive plasmocytosis due to methimazole. Am J Hematol. 67:259-261.
4. Volpe R 1994 Evidence that the immunosuppressive effects of antithyroid drug are mediated through actions on the thyroid cell, modulating thyrocyte-immunocyte signaling. Thyroid 4:217-223.
5. Moreb J, Shemesh O, Shilo S, et al. 1983 Treatment methimazole-induced bone marrow aplasia: In vitro evidence for a humoral mechanism of bone marrow suppression. Acta haematol 69:127-131.
6. Douer D, Eisenstein Z 1988 Methimazole-induced agranulocytosis: Growth inhibition of myeloid progenitor cells by the patient's serum. Eur J Haematol 40:91-94.
7. Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE 1984 In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: A possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab 58:868-8728.
8. Biswas N, Ahn Y, Godman J, Schwartz J. 1991 Case report: Aplastic anemia associated with antithyroid drugs. Am J Med Sci 301:190-194.
9. Hector F, Escobar M, Pilar B 1997 Methimazole-induced severe aplastic anemia: Unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor. Thyroid 7:67-70.
10. Lopez K, Ulloa A, Carlos E 1992 Treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte-monocyte colony-stimulating factor and glucocorticosteroids. Acta Haematol 87:148-150.
11. Mezquita P, Luna V, Munoz M 1998 Methimazole-induced aplastic anemia in third exposure: Successful treatment with recombinant human granulocyte colony-stimulating factor. Thyroid 8:791-794.
12. Tamai H, Mukuta T, Matsubayashi S 1993 Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF). J Clin Endocrinol Metab 77:1356-1360.
13. Tajiri J, Noguchi S, Okamura S 1993 Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia. Arch Intern Med 153:509-514.
14. Fukata S, Kuma K, Sugawara M 1999 Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: A prospective study. Thyroid 9:29-31.